Evidence 1
Activity
Activity
0% Hemolysis
Toxicity
256 µM
Hemolytic
Cytotoxic
0% Hemolysis | 256 | µM | target cell: Mouse erythrocytes
Target
Mouse erythrocytes
Source & Reference
NA
DBAASP
Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria. | Eur J Pharm Sci | 2020